Complete Guide to EUDAMED: Europe's Medical Device Database

EUDAMED — the European Database on Medical Devices — is one of the most ambitious regulatory transparency initiatives ever undertaken in the medical device industry. Established under EU Regulation 2017/745 (MDR) and 2017/746 (IVDR), this centralized platform is designed to give regulators, healthcare professionals, patients, and the public a single authoritative source of information on medical devices circulating in the European market.

For manufacturers, importers, authorized representatives, and notified bodies, EUDAMED is not optional. Understanding its structure, obligations, and current rollout status is essential for any company doing business in the EU.

What Is EUDAMED?

EUDAMED is a web-based IT platform managed by the European Commission. Its purpose is to consolidate device registration data, UDI information, clinical investigation records, vigilance reports, and certificate status into one integrated system. Previously, this information was scattered across national competent authority databases, paper files, and proprietary notified body systems.

The database serves several audiences:

• Regulators and competent authorities use it to coordinate market surveillance and share safety information across EU member states.
• Notified bodies submit and manage certificate data through EUDAMED.
• Manufacturers register devices, upload UDI data, and manage their organizational profiles.
• Healthcare professionals and patients can access public modules to look up device safety information and recall notices.

The 6 Modules of EUDAMED

EUDAMED is built around six interconnected functional modules, each addressing a distinct area of device regulation.

Module 1: Actor Registration (EORI)

This foundational module handles the registration of all economic operators — manufacturers, authorized representatives, importers, and system/procedure pack producers. Each registered actor receives a Single Registration Number (SRN), which becomes their identifier across all other EUDAMED interactions. This module is live and mandatory for EU MDR compliance. Companies must register here before they can interact with any other module.

Module 2: UDI and Device Registration

The Unique Device Identification (UDI) module is the core of EUDAMED's device registry. Manufacturers must assign UDIs to their devices and upload basic device information (BASIC UDI-DI) to this module. The UDI system — modeled on the US FDA's approach — enables traceability across the supply chain and supports rapid recall execution.

Device registration requirements are tiered by risk class: Class III and implantable devices faced the earliest deadlines, followed by Class IIa, IIb, and finally Class I. The data uploaded includes device description, risk class, intended purpose, and the notified body involved (where applicable).

Module 3: Notified Bodies and Certificates

This module tracks the scope of designation for notified bodies and records all certificates they issue, suspend, or withdraw. It provides real-time visibility into the certification status of devices across the EU. Competent authorities and the public can verify whether a device's CE certificate is current and valid — a critical check for procurement and market surveillance.

Module 4: Clinical Investigations and Performance Studies

Under EU MDR and IVDR, sponsors of clinical investigations must register studies in EUDAMED before they begin. This module records study protocols, competent authority decisions, ethics committee opinions, and results. It is intended to function similarly to ClinicalTrials.gov but scoped to EU device studies, improving transparency and reducing duplicative regulatory submissions across member states.

Module 5: Vigilance and Post-Market Surveillance

Manufacturers are required to submit serious incident reports and field safety corrective actions (FSCAs) — essentially recalls or safety notices — through this module. Competent authorities use it to coordinate responses and share information across borders. Post-market surveillance (PMS) plans and periodic safety update reports (PSURs) are also linked here.

Module 6: Market Surveillance

This module supports competent authorities in coordinating market surveillance activities, sharing results of device assessments, and logging enforcement actions. It is primarily a regulatory-facing tool, but its outputs — particularly safety decisions — feed into the public-facing sections of EUDAMED.

Rollout Status and Timeline

EUDAMED's implementation has been phased and, frankly, delayed. The original MDR timeline assumed full EUDAMED functionality by May 2020, but technical development and COVID-19 disruptions pushed the schedule significantly.

As of 2026, the actor registration and UDI/device registration modules are fully operational and mandatory. The notified body and certificates module is live. The vigilance module has been operational for electronic reporting since 2023. The clinical investigations module is active for new studies.

Manufacturers should not wait for further announcements before ensuring full EUDAMED compliance — the system is live and enforcement is increasing across member states.

How Manufacturers Interact with EUDAMED

Manufacturers' interactions with EUDAMED span the entire product lifecycle:

1. Pre-market: Register as an economic operator (Module 1), receive your SRN, register devices and upload UDI data (Module 2), and link your notified body certificate once issued (Module 3).
2. During clinical investigations: Register studies in Module 4 before enrollment begins.
3. Post-market: Submit serious incident reports through Module 5, maintain PMS documentation, and upload PSURs or Summary of Safety and Clinical Performance (SSCP) documents for implantables and Class III devices.

Authorized representatives acting on behalf of non-EU manufacturers carry significant responsibility: they are the registered actor in EUDAMED and share liability for compliance.

Data Visibility: Public vs. Restricted

Not all EUDAMED data is public. The system operates with layered access:

• Publicly accessible: Basic device information, UDI data, certificate validity, serious incident summaries (once closed), SSCP documents for applicable device classes.
• Restricted to competent authorities and notified bodies: Detailed vigilance reports, in-progress investigation data, market surveillance actions.

This distinction matters for competitive intelligence. Publicly available EUDAMED data is a valuable source for monitoring competitor device registrations, tracking notified body certificate status, and identifying new market entrants.

EUDAMED and EU MDR Requirements

EUDAMED is not a standalone obligation — it is woven into the fabric of EU MDR compliance. Article 31 of the MDR requires manufacturers to register in EUDAMED. Articles 26–28 govern UDI and device registration. Article 87 mandates electronic reporting of serious incidents. Non-compliance with EUDAMED obligations can result in enforcement action from national competent authorities and effectively bars a device from the EU market.

The connection between EUDAMED and notified body certificates is particularly important: a certificate that isn't reflected in EUDAMED is of limited value for demonstrating market authorization.

Staying Ahead of EUDAMED Changes

EUDAMED continues to evolve. The European Commission regularly publishes updates to system functionality, data requirements, and guidance documents. Regulatory affairs teams need to monitor these changes continuously — a new data field requirement or a revised EUDAMED interface can trigger internal process changes, system updates, and retraining.

MedFlux monitors EUDAMED updates alongside 26 other global regulators in real time, alerting your team the moment a new guidance document, system update, or enforcement action is published. Don't let an EUDAMED change catch you off guard — let MedFlux keep you ahead of it.